Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient

2009 ◽  
Vol 44 (5) ◽  
pp. 512-515 ◽  
Author(s):  
Luis Máiz ◽  
Adelaida Lamas ◽  
Ana Fernández-Olmos ◽  
Lucrecia Suárez ◽  
Rafael Cantón

2015 ◽  
Vol 305 (1) ◽  
pp. 38-46 ◽  
Author(s):  
Nadine Windmüller ◽  
Anika Witten ◽  
Desirée Block ◽  
Boyke Bunk ◽  
Cathrin Spröer ◽  
...  


2018 ◽  
Author(s):  
Xin Tan ◽  
Mathieu Coureuil ◽  
Elodie Ramond ◽  
Daniel Euphrasie ◽  
Marion Dupuis ◽  
...  

AbstractBackgroundChronic lung infection of cystic fibrosis (CF) patients by Staphylococcus aureus is a well-established epidemiological fact. Indeed, S. aureus is the most commonly identified pathogen in the lungs of CF patients. Strikingly the molecular mechanisms underlying S. aureus persistency are not understood.MethodsWe selected pairs of sequential S. aureus isolates from 3 patients with CF and from one patient with non-CF chronic lung disease. We used a combination of genomic, proteomic and metabolomic approaches with functional assays for in-depth characterization of S. aureus long-term persistence.ResultsFor the first time, we show that late S. aureus isolates from CF patients have an increased ability for intracellular survival in CFBE-F508del cells compared to ancestral early isolates. Importantly, the increased ability to persist intracellularly was confirmed for S. aureus isolates within the own patient F508del epithelial cells. An increased ability to form biofilm was also demonstrated.Furthermore, we identified the underlying genetic modifications inducing altered protein expression profiles and notable metabolic changes. These modifications affect several metabolic pathways and virulence regulators that could constitute therapeutic targets.ConclusionsOur results strongly suggest that the intracellular environment might constitute an important niche of persistence and relapse necessitating adapted antibiotic treatments.SummaryS. aureus persists for years in the lungs of patients with cystic fibrosis despite antibiotic therapies. We demonstrate that S. aureus adaptation leads to increased intracellular persistence suggesting a key role for intracellular niche during S. aureus chronic lung infection.



2016 ◽  
Vol 52 (7) ◽  
pp. 400 ◽  
Author(s):  
Francisco de Borja Martínez Muñiz ◽  
María Martínez Redondo ◽  
Concepción Prados Sánchez ◽  
Julio García Rodríguez


1990 ◽  
Vol 9 (3) ◽  
pp. 234-235 ◽  
Author(s):  
M. Ojeda-Vargas ◽  
A. Pacheco ◽  
M. Elia ◽  
R. Villaverde ◽  
F. Baquero


2013 ◽  
Vol 57 (10) ◽  
pp. 5186-5188 ◽  
Author(s):  
Asmaa Tazi ◽  
Jeanne Chapron ◽  
Gerald Touak ◽  
Magalie Longo ◽  
Dominique Hubert ◽  
...  

ABSTRACTLinezolid has emerged as an important therapeutic option for the treatment ofStaphylococcus aureusin patients with cystic fibrosis. We report the rapid emergence, upon treatment with linezolid, of linezolid-resistantS. aureusclinical isolates through the accumulation of resistance-associated 23S rRNA mutations, together with acquisition of an altered mutator phenotype.



2008 ◽  
Vol 7 ◽  
pp. S45
Author(s):  
D. Claeys ◽  
M.V. Guillot ◽  
C.C. El Hachem ◽  
N. Curcio ◽  
C. Paris ◽  
...  


2016 ◽  
Vol 2 (1) ◽  
pp. 00064-2015 ◽  
Author(s):  
Emilie Vallières ◽  
Jacqueline C. Rendall ◽  
John E. Moore ◽  
John McCaughan ◽  
Anne I. Hoeritzauer ◽  
...  

UK cystic fibrosis (CF) guidelines recommend eradication of methicillin-resistant Staphylococcus aureus (MRSA) when cultured from respiratory samples. As there is no clear consensus as to which eradication regimen is most effective, we determined the efficacy of eradication regimens used in our CF centre and long-term clinical outcome.All new MRSA positive sputum cultures (n=37) that occurred between 2000 and 2014 were reviewed. Eradication regimen characteristics and clinical, microbiological and long-term outcome data were collected.Rifampicin plus fusidic acid was the most frequently used regimen (24 (65%) out of 37 patients), with an overall success rate of 79% (19 out of 24 patients). Eradication failure was more likely in patients with an additional MRSA-positive peripheral screening swab (p=0.03) and was associated with worse survival (p=0.04).Our results demonstrate the feasibility and clinical benefits of MRSA eradication. As peripheral colonisation was associated with lower eradication success, strategies combining systemic and topical treatments should be considered to optimise outcomes in CF patients.



2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Thayer G. Ismaael ◽  
Eleana M. Zamora ◽  
Faisal A. Khasawneh

Chronic airway colonization and infection are the hallmark of cystic fibrosis (CF).Staphylococcus aureus, Pseudomonas aeruginosa, andBurkholderia cepaciaare well-documented bacterial culprits in this chronic suppurative airway disease. Advanced molecular diagnostics have uncovered a possible role of a larger group of microorganisms in CF.Cedeceais a member of the family Enterobacteriaceae and is an emerging pathogen. We present a case of a polymicrobial healthcare-associated pneumonia in a CF patient caused byCedecea davisae, among other bacteria.



2018 ◽  
Vol 308 (6) ◽  
pp. 631-639 ◽  
Author(s):  
Mathias Schwerdt ◽  
Claudia Neumann ◽  
Bianca Schwartbeck ◽  
Stefanie Kampmeier ◽  
Susann Herzog ◽  
...  


2012 ◽  
Vol 48 (10) ◽  
pp. 384 ◽  
Author(s):  
Luis Máiz ◽  
Rosa Del Campo ◽  
María Castro ◽  
Dayra Gutiérrez ◽  
Rosa Girón ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document